JPS5120580U - - Google Patents
Info
- Publication number
- JPS5120580U JPS5120580U JP9200174U JP9200174U JPS5120580U JP S5120580 U JPS5120580 U JP S5120580U JP 9200174 U JP9200174 U JP 9200174U JP 9200174 U JP9200174 U JP 9200174U JP S5120580 U JPS5120580 U JP S5120580U
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9200174U JPS522706Y2 (https=) | 1974-07-31 | 1974-07-31 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9200174U JPS522706Y2 (https=) | 1974-07-31 | 1974-07-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5120580U true JPS5120580U (https=) | 1976-02-14 |
| JPS522706Y2 JPS522706Y2 (https=) | 1977-01-21 |
Family
ID=28281906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9200174U Expired JPS522706Y2 (https=) | 1974-07-31 | 1974-07-31 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS522706Y2 (https=) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11667635B2 (en) | 2015-02-20 | 2023-06-06 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| US11897891B2 (en) | 2019-12-04 | 2024-02-13 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
| US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US12024517B2 (en) | 2018-05-04 | 2024-07-02 | Incyte Corporation | Salts of an FGFR inhibitor |
| US12065494B2 (en) | 2021-04-12 | 2024-08-20 | Incyte Corporation | Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent |
| US12083124B2 (en) | 2019-10-14 | 2024-09-10 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US12122767B2 (en) | 2019-10-01 | 2024-10-22 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US12168660B2 (en) | 2019-12-04 | 2024-12-17 | Incyte Corporation | Derivatives of an FGFR inhibitor |
-
1974
- 1974-07-31 JP JP9200174U patent/JPS522706Y2/ja not_active Expired
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11667635B2 (en) | 2015-02-20 | 2023-06-06 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| US12024517B2 (en) | 2018-05-04 | 2024-07-02 | Incyte Corporation | Salts of an FGFR inhibitor |
| US12122767B2 (en) | 2019-10-01 | 2024-10-22 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US12083124B2 (en) | 2019-10-14 | 2024-09-10 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US11897891B2 (en) | 2019-12-04 | 2024-02-13 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
| US12168660B2 (en) | 2019-12-04 | 2024-12-17 | Incyte Corporation | Derivatives of an FGFR inhibitor |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US12065494B2 (en) | 2021-04-12 | 2024-08-20 | Incyte Corporation | Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent |
| US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS522706Y2 (https=) | 1977-01-21 |